1. Incidence and outcome of adenovirus disease in transplant recipients after reduced- intensity conditioning with alemtuzumab 
Irit Avivi, Suparno Chakrabarti, Donald W Milligan, H Waldmann, Geoff Hale, Husam Osman, Katherine N Ward, Christopher D Fegan, Kwee Yong, Anthony H Goldstone, David C Linch, Stephen MacKinnon 
Biology of Blood and Marrow Transplantation 
Volume 10, Issue 3, Pages (March 2004)
DOI: /j.bbmt

2. Figure 1
Incidence of adenovirus disease after reduced-intensity transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )

3. Figure 2
A scatter plot showing the relationship between adenovirus-related deaths and absolute lymphocyte count (y-axis) in relation to the immunosuppressive therapy (IST; x-axis). The circles and crosses represent patients with and without adenovirus-related deaths, respectively.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )

4. Figure 3
Nonrelapse mortality among reduced-intensity transplant recipients in relation to adenovirus disease.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )